Dalphene Labs · The business of medical aestheticsFor owners, injectors & clinic teamsJoin the brief

Dalphene Labs

Medical aesthetics
Compliance

Regulation, scope of practice, and the rulings that protect the clinic.

22 briefs

Lead · Compliance

New York Extends Independent Practice Authority for Qualified Nurse Practitioners

New York Extends Independent Practice Authority for Qualified Nurse Practitioners

New York Extends Independent Practice Authority for Qualified Nurse Practitioners Through 2030

New York has extended independent practice authority for qualified nurse practitioners through July 1, 2030, allowing established clinics to maintain their current staffing and supervisory structures without abrupt operational shifts. The extension preserves the regulatory framework originally established in 2022, which was previously set to expire on July 1, 2026. Under these rules, nurse practitioners who have completed at least 3,600 hours of qualifying practice can continue to practice, prescribe, and operate clinics without a written collaborative agreement or protocol with a physician.

Read the full brief →

More in Compliance

FDA issues Complete Response Letter for Galderma's liquid neuromodulator

Compliance

FDA issues Complete Response Letter for Galderma's liquid neuromodulator

FDA Issues Complete Response Letter for Galderma’s Ready-to-Use Liquid Neuromodulator BLA

Read the brief →
Regulators enforce strict divide between topical and injectable exosomes

Compliance

Regulators enforce strict divide between topical and injectable exosomes

Compliance Audit: The Strict Regulatory Divide Governing Topical vs. Injectable Exosomes

Read the brief →
University of Miami launches aesthetic medicine certificate for Florida nurse practitioners

Compliance

University of Miami launches aesthetic medicine certificate for Florida nurse practitioners

University of Miami Launches Academic Post-Graduate Certificate in Aesthetic Medicine for APRNs

Read the brief →
Filler death of Estée Lauder executive ruled an accident

Compliance

Filler death of Estée Lauder executive ruled an accident

A high-profile filler fatality, ruled an accident, that comes down to intravascular injection.

Read the brief →
FDA committee to review compounding eligibility for seven peptides in July

Compliance

FDA committee to review compounding eligibility for seven peptides in July

FDA's July 2026 PCAC Meeting Scheduled to Review Peptide Compounding Eligibility

Read the brief →
South Korea tightens medical device quality and distribution rules for 2026

Compliance

South Korea tightens medical device quality and distribution rules for 2026

South Korea's Amended Medical Device Act Tightens QMS and Distribution Rules

Read the brief →
Rhode Island passes law requiring med spas to license as healthcare facilities

Compliance

Rhode Island passes law requiring med spas to license as healthcare facilities

Rhode Island Medical Spas Safety Act Healthcare Licensure Rules Take Effect

Read the brief →
FDA issues complete response letter to Galderma for RelabotulinumtoxinA

Compliance

FDA issues complete response letter to Galderma for RelabotulinumtoxinA

Galderma Progresses FDA Regulatory Review for RelabotulinumtoxinA

Read the brief →
United Kingdom will require licensing for cosmetic injectables starting July 2026

Compliance

United Kingdom will require licensing for cosmetic injectables starting July 2026

UK Cosmetic Injectables Registration and Accreditation Deadline Approaches

Read the brief →
Texas Medical Board Tightens Rules on Med Spa Delegation and Signage

Compliance

Texas Medical Board Tightens Rules on Med Spa Delegation and Signage

Texas Medical Board Intensifies Signage and Delegation Rules for Med Spas

Read the brief →
South Korea launches cosmetic safety portal ahead of mandatory assessment phase in

Compliance

South Korea launches cosmetic safety portal ahead of mandatory assessment phase in

South Korea Phase-In of Mandatory Cosmetic Safety Assessments Begins with Support Portal Launch

Read the brief →
FDA clears Epiduo acne gel for over the counter sale

Compliance

FDA clears Epiduo acne gel for over the counter sale

FDA Approves Differin Epiduo Acne Gel for Over-the-Counter Use

Read the brief →
FDA sends 25 warning letters over compounded GLP-1 marketing

Compliance

FDA sends 25 warning letters over compounded GLP-1 marketing

Third enforcement wave in under a year, and the exposure is in your marketing copy.

Read the brief →
South Korea bans 'insurance-eligible' ads for non-covered cosmetic care

Compliance

South Korea bans 'insurance-eligible' ads for non-covered cosmetic care

Penalties for patient-inducing ads roughly triple, to a six-month license suspension.

Read the brief →

Compliance

South Korea Establishes New Regulatory Association for Cosmetics Export Laws

South Korea Establishes Food and Cosmetics Law Association

Read the brief →
Japan regulator warns on subscription billing in online beauty consults

Compliance

Japan regulator warns on subscription billing in online beauty consults

Auto-refills shipping a year of product with no physician reassessment.

Read the brief →
South Korea legalizes telemedicine for foreign patients

Compliance

South Korea legalizes telemedicine for foreign patients

Remote first-time consults for foreign patients, aimed straight at cosmetic medical tourism.

Read the brief →
Georgia bans paid 'ghost director' deals at med spas

Compliance

Georgia bans paid 'ghost director' deals at med spas

The board will judge the practical reality of oversight, not the paperwork.

Read the brief →